These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14908789)

  • 1. Active immunity in mice following the intranasal injection of sublethal doses of living Haemophilus pertussis.
    COOPER GN
    J Pathol Bacteriol; 1952 Jan; 64(1):65-74. PubMed ID: 14908789
    [No Abstract]   [Full Text] [Related]  

  • 2. The intranasal infection of mice with Bordetella pertussis.
    DOLBY JM; THOW DC; STANDFAST AF
    J Hyg (Lond); 1961 Jun; 59(2):191-204. PubMed ID: 13723506
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.
    Standfast AF; Dolby JM
    J Hyg (Lond); 1972 Sep; 70(3):487-501. PubMed ID: 4341998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines.
    Guiso N; Capiau C; Carletti G; Poolman J; Hauser P
    Vaccine; 1999 May; 17(19):2366-76. PubMed ID: 10392618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whooping cough; pertussis agglutinogen skin test after immunization with Hemophilus pertussis vaccine.
    SAUER LW; MARKLEY ED
    J Am Med Assoc; 1946 Jul; 131():967-9. PubMed ID: 20989980
    [No Abstract]   [Full Text] [Related]  

  • 6. The active immunization of mice against an intracerebral infection of Haemophilus pertussis organisms by intranasal instillation of H. pertussis antigens.
    BROWN AM
    J Gen Microbiol; 1953 Feb; 8(1):iii. PubMed ID: 13035052
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation.
    Mielcarek N; Debrie AS; Raze D; Quatannens J; Engle J; Goldman WE; Locht C
    Vaccine; 2006 Apr; 24 Suppl 2():S2-54-5. PubMed ID: 16823926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aerosol inoculation of Bordetella pertussis in mice].
    Sato Y; Arai H
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):198. PubMed ID: 175185
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M; Cropley I; Chatfield S; Dougan G
    Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
    Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
    PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
    Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effects of human gamma globulin preparations against experimental aerosol infections of mice with Bordetella pertussis].
    Imaizumi A; Suzuki Y; Sato Y
    Kansenshogaku Zasshi; 1984 Jun; 58(6):518-24. PubMed ID: 6092492
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
    Alonso JM; Rocancourt M; Le Nin S; Brezin C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison between pertussis vaccine potency assays in mice challenged by the intracerebral route and mice challenged by the intranasal route (sublethal dose).
    ANDERSEN EK; BENTZON MW
    Acta Pathol Microbiol Scand; 1958; 42(4):333-56. PubMed ID: 13532706
    [No Abstract]   [Full Text] [Related]  

  • 18. [Whooping cough--a toxicosis?].
    Finger H; Wirsing von König CH
    Dtsch Med Wochenschr; 1986 Jun; 111(24):950-4. PubMed ID: 2872045
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant.
    Shi W; Kou Y; Jiang H; Gao F; Kong W; Su W; Xu F; Jiang C
    Immunol Lett; 2018 Jun; 198():26-32. PubMed ID: 29601940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.